Nano-PROTACs: state of the art and perspectives-Reference-Cited by-同舟云学术

Nano-PROTACs: state of the art and perspectives

Published:2024 Issue:9 Volume:16 Page:4378-4391
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Zhong Jie¹²^ORCID,Zhao Ruiqi²,Wang Yuji¹^ORCID,Su Yu-xiong²^ORCID,Lan Xinmiao¹^ORCID

Affiliation:

1. Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China

2. Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR 999077, China

Abstract

Schematic illustration of the combinational strategy of nanotechnology and PROTACs (Nano-PROTACs): the typical shortcomings of traditional PROTACs and the nanotechnology-based strategies for PROTAC drugs optimization.

Funder

University of Hong Kong

Beijing Municipal Commission of Education

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NR/D3NR06059D

Reference100 articles.

1. PROTACs: past, present and future

2. Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation